Literature DB >> 15488185

Analysis of G-protein-coupled receptor kinase RGS homology domains.

Peter W Day1, Philip B Wedegaertner, Jeffrey L Benovic.   

Abstract

G-protein-coupled receptor kinases (GRKs) specifically phosphorylate agonist-occupied G-protein-coupled receptors (GPCRs). All seven mammalian GRKs contain an N-terminal domain that is homologous to the regulator of G-protein signaling (RGS) family of proteins. The RGS domain of GRK2 has been shown to interact specifically with Galphaq family members. While the specificity and functional consequences of GRK/Galpha interaction remain somewhat poorly defined, GRK RGS homology (RH) domains likely function to provide specificity for GRK interaction with a particular Galpha subunit or GPCR/Galpha complex. Indeed, GRK2 binds Galphaq, alpha11, and alpha14, but not Galpha16, Galphas, Galphai, or Galpha(12/13), while the RGS domains of GRK5 and GRK6 do not bind Galpha(q/11), Galphas, Galphai, or Galpha(12/13). In this chapter we describe various in vitro and intact cell strategies that can be used to elucidate the function of GRK RH domains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488185     DOI: 10.1016/S0076-6879(04)90019-5

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  13 in total

Review 1.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

2.  Roles of phosphorylation-dependent and -independent mechanisms in the regulation of histamine H2 receptor by G protein-coupled receptor kinase 2.

Authors:  Natalia Fernandez; Federico L Gottardo; Maria N Alonso; Federico Monczor; Carina Shayo; Carlos Davio
Journal:  J Biol Chem       Date:  2011-06-24       Impact factor: 5.157

Review 3.  Targeting GPCR-Gβγ-GRK2 signaling as a novel strategy for treating cardiorenal pathologies.

Authors:  Valeria Rudomanova; Burns C Blaxall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-01-25       Impact factor: 5.187

Review 4.  Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials.

Authors:  Joseph B O'Brien; Joshua C Wilkinson; David L Roman
Journal:  J Biol Chem       Date:  2019-10-21       Impact factor: 5.157

Review 5.  G protein-coupled receptor kinases as regulators of dopamine receptor functions.

Authors:  Eugenia V Gurevich; Raul R Gainetdinov; Vsevolod V Gurevich
Journal:  Pharmacol Res       Date:  2016-05-10       Impact factor: 7.658

6.  An N-terminal polybasic motif of Gαq is required for signaling and influences membrane nanodomain distribution.

Authors:  Marykate Crouthamel; Daniel Abankwa; Li Zhang; Cherisse DiLizio; David R Manning; John F Hancock; Philip B Wedegaertner
Journal:  Mol Pharmacol       Date:  2010-07-27       Impact factor: 4.436

Review 7.  Analyzing the roles of multi-functional proteins in cells: The case of arrestins and GRKs.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Crit Rev Biochem Mol Biol       Date:  2015       Impact factor: 8.250

8.  N-terminal polybasic motifs are required for plasma membrane localization of Galpha(s) and Galpha(q).

Authors:  Marykate Crouthamel; Manimekalai M Thiyagarajan; Daniel S Evanko; Philip B Wedegaertner
Journal:  Cell Signal       Date:  2008-07-02       Impact factor: 4.315

Review 9.  The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.

Authors:  Jonathan Hullmann; Christopher J Traynham; Ryan C Coleman; Walter J Koch
Journal:  Pharmacol Res       Date:  2016-05-12       Impact factor: 7.658

10.  Endocytosis of the seven-transmembrane RGS1 protein activates G-protein-coupled signalling in Arabidopsis.

Authors:  Daisuke Urano; Nguyen Phan; Janice C Jones; Jing Yang; Jirong Huang; Jeffrey Grigston; J Philip Taylor; Alan M Jones
Journal:  Nat Cell Biol       Date:  2012-09-02       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.